4.38
4.38 (0%)
As of Feb 14, 2025
Chimerix Inc [CMRX]
Source:
Company Overview
Chimerix Inc is a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases.
| Country | United States |
| Headquarters | durham, north carolina |
| Phone Number | 919.806.1074 |
| Industry | manufacturing |
| CEO | Michael T. Andriole |
| Website | www.chimerix.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $0.2 |
| Operating Profit | $-96.6 |
| Net Income | $-88.4 |
| Net Cash | $3.4 |
Profit Ratios
| Gross Margin | $0.2 |
| Operating Margin | -45,550.5 |
| Profit as % of Revenues | -0.2% |
| Profit as % of Assets | -49.3% |
| Profit as % of Stockholder Equity | -72.6% |
Management Effectiveness
| Return on Equity | -72.6% |
| Return on Assets | -60.5% |
| Turnover Ratio | 0.1% |
| EBITA | $-96.6 |
Balance Sheet and Cash Flow Measures
| Total Assets | $146 |
| Total Liabilities | $24.3 |
| Operating Cash Flow | $-75 |
| Investing Cash Flow | $71.3 |
| Financing Cash Flow | $7 |
